Japanese encephalitis
Mosquito-borne brain infection endemic in Asia and the Western Pacific.
Japanese encephalitis is a brain infection caused by the Japanese encephalitis virus (JEV). The virus is mainly spread by Culex mosquitoes, with pigs and wild birds acting as reservoirs. Most people infected show few or no symptoms, but in some cases—about 1 in 250 infections—the brain becomes inflamed. When this happens, symptoms like headache, vomiting, fever, confusion, and seizures appear roughly 5 to 15 days after infection. The incubation period can range from 2 to 26 days. Severe chills may mark the start of the illness, followed by fever, headache, and general discomfort that can last 1 to 6 days. During the acute encephalitic stage, signs can include a stiff neck, wasting, weakness on one side of the body, convulsions, and a high fever between 38 and 43 °C. The mortality rate is around 25%, higher in children under five, the immunosuppressed, and the elderly. Among survivors, up to half experience permanent problems, with neurological disorders developing in 40% of those who had central nervous system involvement. Lifelong issues such as deafness, emotional instability, and hemiparesis can occur.
Diagnosis relies on testing blood or cerebrospinal fluid for JEV-specific IgM antibodies, often using an IgM capture ELISA. These antibodies are usually detectable 3 to 8 days after symptoms start and persist for 30 to 90 days, though longer persistence is possible, meaning a positive result could reflect past infection or vaccination. Serum collected within 10 days of illness onset may not yet show IgM.
There is no specific treatment for Japanese encephalitis once infected; care is supportive and typically given in a hospital. Prevention is achieved with a safe and effective vaccine, along with avoiding mosquito bites. The disease occurs mostly outside of cities, primarily in East and Southeast Asia and the Western Pacific. About 3 billion people live in affected areas. Roughly 68,000 symptomatic cases occur each year, leading to about 17,000 deaths, often in outbreaks. The disease was first described in Japan in 1871.
JEV is a flavivirus, part of the Japanese encephalitis serocomplex, which includes nine related viruses—some severe in horses, and four, including West Nile virus, that infect humans. It is closely related to West Nile and St. Louis encephalitis viruses. The virus has a positive-sense single-
- first described
- 1871 (Japan)
- caused by
- Japanese encephalitis virus (JEV)
- transmission
- Mosquitoes (Culex type)
- reservoir
- Pigs and wild birds
- annual symptomatic cases
- ~68,000
- annual deaths
- ~17,000
- mortality rate
- ~25%
Quick Facts
- Field
- Infectious disease
- Symptoms
- Headache, fever, vomiting, confusion, seizures
- Onset
- 5 to 15 days after infection
- Causes
- Japanese encephalitis virus (spread by mosquitoes)
- Diagnosis
- Blood or cerebrospinal fluid testing
- Prevention
- Japanese encephalitis vaccine, avoiding mosquito bites
- Treatment
- Supportive care
- Prognosis
- Permanent neurological problems occur in up to half of survivors
- Frequency
- 68,000
- Deaths
- 17,000
Facts from the source article.
Lore & Background
Japanese encephalitis is caused by the mosquito-borne Japanese encephalitis virus, a member of the Flaviviridae family. The virus has an incubation period of 2 to 26 days, and the vast majority of infections are asymptomatic. Only about 1 in 250 infections develop into encephalitis, with symptoms including fever, headache, vomiting, confusion, and seizures occurring 5 to 15 days after infection. Severe cases may involve neck rigidity, convulsions, and a raised body temperature between 38–43 °C. The mortality rate is around 25%, higher in children under five, the immunosuppressed, and the elderly.
Reader's Guide
Japanese encephalitis remains a significant public health concern in East and Southeast Asia and the Western Pacific, where about 3 billion people live in endemic areas. Approximately 68,000 symptomatic cases occur annually, with about 17,000 deaths. The disease often occurs in outbreaks. Prevention is achieved with the Japanese encephalitis vaccine, which is both safe and effective, along with measures to avoid mosquito bites. There is no specific treatment; care is supportive and generally carried out in a hospital. Permanent neurological problems occur in up to half of people who recover, including lifelong defects such as deafness, emotional lability, and hemiparesis. The virus is maintained in a cycle involving Culex mosquitoes and reservoir hosts such as pigs and wild birds. Diagnosis is based on detecting JE virus-specific IgM antibodies in serum or cerebrospinal fluid. The disease was first described in Japan in 1871, and the virus appears to have evolved in the mid-16th century.
Did You Know?
- The disease was first described in Japan in 1871.
- Only 1 in 250 infections develop into encephalitis.
- Pigs and wild birds serve as a reservoir for the virus.
- Permanent problems occur in up to half of people who recover from JE.
Frequently Asked Questions
Who is Japanese encephalitis?
Japanese encephalitis is a mosquito-borne brain infection caused by the Japanese encephalitis virus (JEV), first identified in Japan in 1871. It is endemic across Asia and the Western Pacific region.
What are Japanese encephalitis's powers/role?
It spreads primarily through Culex mosquitoes, relying on pigs and wild birds as its reservoir hosts. Most encounters with the virus go unnoticed, but roughly 1 in 250 infections escalates into dangerous brain inflammation.
How does Japanese encephalitis's story end?
When the infection turns severe, victims face fever, confusion, seizures, and vomiting within about 5 to 15 days of the initial bite. Tragically, around 17,000 people die from it each year out of roughly 68,000 symptomatic cases.
Why is Japanese encephalitis important?
It remains one of the most significant mosquito-borne neurological threats in the Asia-Pacific region, claiming tens of thousands of lives annually. Its deep reservoir in livestock and wildlife makes long-term eradication extremely difficult.
What's Japanese encephalitis's backstory/origin?
The condition was first documented in Japan in 1871, where it was observed as a recurring seasonal brain illness. Its incubation window spans anywhere from 2 to 26 days, meaning the virus can lie dormant in a host for nearly a month before symptoms surface.
More in Viral Infections 1-20
Spotted an error? Know more?
This is a living reference — every entry is fact-audited, and reader corrections feed straight into our audit queue. Suggest an edit · See this site's audit record